Elza Muscelli Selected Research

Glycosuria

1/2017	Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.
4/2016	Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.
1/2016	Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
2/2014	Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elza Muscelli Research Topics

Disease

22	Insulin Resistance 11/2021 - 12/2003
16	Type 2 Diabetes Mellitus (MODY) 03/2022 - 05/2008
6	Glucose Intolerance 06/2014 - 12/2006
6	Weight Loss (Weight Reduction) 11/2013 - 12/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2009
4	Glycosuria 01/2017 - 02/2014
4	Obesity 07/2010 - 12/2004
3	Hyperglycemia 01/2022 - 05/2008
3	Morbid Obesity 01/2011 - 01/2005
3	Body Weight (Weight, Body) 04/2009 - 12/2003
2	Overweight 08/2011 - 03/2009
1	Atherosclerosis 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Inflammation (Inflammations) 11/2021
1	Ketosis 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2016
1	Weight Gain 07/2011
1	Dyslipidemias (Dyslipidemia) 10/2010
1	Essential Hypertension 09/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2009
1	Stroke (Strokes) 07/2008
1	Hypertension (High Blood Pressure) 02/2008

Drug/Important Bio-Agent (IBA)

27	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2003
17	Insulin (Novolin)FDA Link 11/2021 - 12/2003
5	AdiponectinIBA 03/2022 - 07/2008
5	IncretinsIBA 01/2022 - 12/2006
5	LipidsIBA 01/2018 - 12/2003
4	empagliflozinIBA 01/2020 - 02/2014
4	Glucagon (Glukagon)FDA Link 01/2018 - 08/2012
4	Hormones (Hormone)IBA 01/2017 - 01/2005
4	C-PeptideIBA 06/2014 - 12/2006
3	SodiumIBA 01/2020 - 04/2016
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018 - 03/2009
2	dapagliflozinIBA 03/2022 - 12/2021
2	Nonesterified Fatty Acids (NEFA)IBA 11/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2004
2	Sodium-Glucose Transport ProteinsIBA 01/2017 - 01/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2016 - 01/2016
2	CarbohydratesIBA 01/2016 - 03/2009
2	Triglycerides (Triacylglycerol)IBA 12/2009 - 02/2008
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2021
1	thrombospondin 4IBA 01/2020
1	Leptin ReceptorsIBA 01/2020
1	CeramidesIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	ApoferritinsIBA 01/2020
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2020
1	Neutral CeramidaseIBA 01/2020
1	SphingosineIBA 01/2020
1	neogeninIBA 01/2020
1	IronIBA 01/2020
1	ReninIBA 01/2020
1	Growth Differentiation Factor 2IBA 01/2020
1	Fatty Acid Binding Protein 3IBA 01/2020
1	acipimoxIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	KetonesIBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 04/2016
1	SymportersIBA 04/2016
1	Peptides (Polypeptides)IBA 06/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2012
1	Sitagliptin Phosphate (Januvia)FDA Link 08/2012
1	Hemoglobin AIBA 08/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2012
1	Vasodilator Agents (Vasodilators)IBA 01/2011
1	FHDIBA 10/2010
1	HLA-G Antigens (HLA G)IBA 07/2010
1	Interleukin-10 (Interleukin 10)IBA 07/2010
1	Interleukin-6 (Interleukin 6)IBA 07/2010
1	Biomarkers (Surrogate Marker)IBA 07/2010
1	CholesterolIBA 07/2010
1	CytokinesIBA 07/2010
1	AdipokinesIBA 09/2009
1	Vitamin A (Retinol)FDA LinkGeneric 09/2009
1	LDL CholesterolIBA 04/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2009
1	Phenobarbital (Luminal)FDA Link 04/2009
1	HDL CholesterolIBA 03/2009
1	Protein Isoforms (Isoforms)IBA 07/2008
1	baysilon (polydimethylsiloxane)IBA 12/2003

Therapy/Procedure

6	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2013 - 12/2003
3	Bariatric Surgery 03/2009 - 12/2003
2	Biliopancreatic Diversion 07/2013 - 01/2005
1	Glycemic Control 08/2012
1	Gastrectomy 08/2011
1	Diet Therapy (Therapy, Diet) 03/2009